Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,194 | -6,700 | -12,019 | -15,052 | -16,656 |
| Depreciation Amortization | 4 | 4 | 351 | 388 | 2,074 |
| Accounts payable and accrued liabilities | -288 | 140 | 37 | 6 | 148 |
| Other Working Capital | -570 | -394 | 427 | -797 | 4,736 |
| Other Operating Activity | 953 | -8 | 878 | 1,260 | 3,573 |
| Operating Cash Flow | $-14,095 | $-6,958 | $-10,326 | $-14,196 | $-6,125 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -2 | -92 | -191 | -259 |
| Net Acquisitions | 1,030 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,000 |
| Investing Cash Flow | $967 | $-2 | $-92 | $-191 | $741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,500 | N/A | N/A | N/A | 650 |
| Debt Repayment | N/A | N/A | N/A | N/A | -100 |
| Common Stock Issued | 21,507 | N/A | 13,286 | 648 | 28,485 |
| Common Stock Repurchased | N/A | N/A | -5 | N/A | N/A |
| Other Financing Activity | -69 | 7,995 | -186 | 0 | -598 |
| Financing Cash Flow | $26,938 | $7,995 | $13,095 | $648 | $28,437 |
| Beginning Cash Position | 1,834 | 799 | 9,906 | 23,645 | 592 |
| End Cash Position | 15,644 | 1,834 | 12,584 | 9,906 | 23,645 |
| Net Cash Flow | $13,810 | $1,036 | $2,677 | $-13,738 | $23,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,095 | -6,958 | -10,326 | -14,196 | -6,125 |
| Capital Expenditure | -63 | -2 | -92 | -191 | -259 |
| Free Cash Flow | -14,158 | -6,959 | -10,418 | -14,386 | -6,385 |